Edgewise Therapeutics, Inc. (EWTX) Earnings
|
Expand Research on EWTX
| Next EPS Date | 11/5/26 | EPS Growth Rate | -38.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -2.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.54 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | -$0.53 | -$0.47 | -$0.06 | N/A | N/A | N/A |  | | Details | |
| 5/7/26 | Q126 | -$0.46 | -$0.49 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 2/26/26 | Q425 | -$0.47 | -$0.44 | -$0.03 | N/A | N/A | N/A | | | Details | |
| 2/24/26 |
Q425 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/23/26 |
Q425 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/20/26 |
Q425 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/19/26 |
Q425 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A |
